User login
To help SVS members learn the necessary steps of setting up a multicenter clinical research study, this year’s Vascular Annual Meeting offers “The Nuts and Bolts of a Multicenter Clinical Trial.” The concurrent session will be held from 5 to 6:30 p.m. Wednesday, VAM’s opening day.
“The most accepted method of definitively answering questions is a clinical trial,” said SVS Clinical Research Committee Chair and co-moderator, Dr. Raul Guzman. Though many SVS members have participated in multicenter trials, “They’re not easy endeavors,” said Dr. Guzman. “It takes time, commitment and money to really push forward an idea for a multicenter trial from the ground up.”
“Nuts and Bolts” will provide an insider’s view of effective approaches and processes for launching a multicenter clinical trial, focusing on the best strategies and the challenges involved. “We hope that at the end of the session, attendees will have sufficient detail about this process so they could begin their own trial. We want to provide an initial education,” Dr. Guzman said.
Speakers include SVS members who are successful clinical investigators:
Dr. Brajesh Lal, will speak on “How to Get Started – Perspectives from CREST and CREST-2”
Dr. Alik Farber, “Trial Execution – Tips from the BEST-CLI Trial Investigators”
Dr. B. Timothy Baxter, “The End Game, Finishing Your Trial – How We Did It in NTA^3CT”
Dr. C. Keith Ozaki, “The Small Multicenter Randomized Trial – Involving Your Friends and Neighbors”
Dr. Philip Goodney, “Patient-Oriented Research – A Multicenter Approach to PCORI Trials”
“A discussion about how to overcome challenges and avoid potential pitfalls that can be encountered during the various stages of trial execution are an important part of the course. “Our speakers will discuss not only what they did well, but what they could do better,” said Dr. Guzman.
Many members have questions that need answers, he said. “I would venture to say that most SVS members have had an idea for a clinical trial. They’ve formed the basis of a trial but there are so many challenges that they’ve been discouraged. One of the questions is, “Where do you even start?’
“We think we’ll be able to answer that for them,” Dr. Guzman said.
Wednesday, May 31
5 – 6:30 p.m.
C2: The Nuts and Bolts of a Multicenter Clinical Trial
To help SVS members learn the necessary steps of setting up a multicenter clinical research study, this year’s Vascular Annual Meeting offers “The Nuts and Bolts of a Multicenter Clinical Trial.” The concurrent session will be held from 5 to 6:30 p.m. Wednesday, VAM’s opening day.
“The most accepted method of definitively answering questions is a clinical trial,” said SVS Clinical Research Committee Chair and co-moderator, Dr. Raul Guzman. Though many SVS members have participated in multicenter trials, “They’re not easy endeavors,” said Dr. Guzman. “It takes time, commitment and money to really push forward an idea for a multicenter trial from the ground up.”
“Nuts and Bolts” will provide an insider’s view of effective approaches and processes for launching a multicenter clinical trial, focusing on the best strategies and the challenges involved. “We hope that at the end of the session, attendees will have sufficient detail about this process so they could begin their own trial. We want to provide an initial education,” Dr. Guzman said.
Speakers include SVS members who are successful clinical investigators:
Dr. Brajesh Lal, will speak on “How to Get Started – Perspectives from CREST and CREST-2”
Dr. Alik Farber, “Trial Execution – Tips from the BEST-CLI Trial Investigators”
Dr. B. Timothy Baxter, “The End Game, Finishing Your Trial – How We Did It in NTA^3CT”
Dr. C. Keith Ozaki, “The Small Multicenter Randomized Trial – Involving Your Friends and Neighbors”
Dr. Philip Goodney, “Patient-Oriented Research – A Multicenter Approach to PCORI Trials”
“A discussion about how to overcome challenges and avoid potential pitfalls that can be encountered during the various stages of trial execution are an important part of the course. “Our speakers will discuss not only what they did well, but what they could do better,” said Dr. Guzman.
Many members have questions that need answers, he said. “I would venture to say that most SVS members have had an idea for a clinical trial. They’ve formed the basis of a trial but there are so many challenges that they’ve been discouraged. One of the questions is, “Where do you even start?’
“We think we’ll be able to answer that for them,” Dr. Guzman said.
Wednesday, May 31
5 – 6:30 p.m.
C2: The Nuts and Bolts of a Multicenter Clinical Trial
To help SVS members learn the necessary steps of setting up a multicenter clinical research study, this year’s Vascular Annual Meeting offers “The Nuts and Bolts of a Multicenter Clinical Trial.” The concurrent session will be held from 5 to 6:30 p.m. Wednesday, VAM’s opening day.
“The most accepted method of definitively answering questions is a clinical trial,” said SVS Clinical Research Committee Chair and co-moderator, Dr. Raul Guzman. Though many SVS members have participated in multicenter trials, “They’re not easy endeavors,” said Dr. Guzman. “It takes time, commitment and money to really push forward an idea for a multicenter trial from the ground up.”
“Nuts and Bolts” will provide an insider’s view of effective approaches and processes for launching a multicenter clinical trial, focusing on the best strategies and the challenges involved. “We hope that at the end of the session, attendees will have sufficient detail about this process so they could begin their own trial. We want to provide an initial education,” Dr. Guzman said.
Speakers include SVS members who are successful clinical investigators:
Dr. Brajesh Lal, will speak on “How to Get Started – Perspectives from CREST and CREST-2”
Dr. Alik Farber, “Trial Execution – Tips from the BEST-CLI Trial Investigators”
Dr. B. Timothy Baxter, “The End Game, Finishing Your Trial – How We Did It in NTA^3CT”
Dr. C. Keith Ozaki, “The Small Multicenter Randomized Trial – Involving Your Friends and Neighbors”
Dr. Philip Goodney, “Patient-Oriented Research – A Multicenter Approach to PCORI Trials”
“A discussion about how to overcome challenges and avoid potential pitfalls that can be encountered during the various stages of trial execution are an important part of the course. “Our speakers will discuss not only what they did well, but what they could do better,” said Dr. Guzman.
Many members have questions that need answers, he said. “I would venture to say that most SVS members have had an idea for a clinical trial. They’ve formed the basis of a trial but there are so many challenges that they’ve been discouraged. One of the questions is, “Where do you even start?’
“We think we’ll be able to answer that for them,” Dr. Guzman said.
Wednesday, May 31
5 – 6:30 p.m.
C2: The Nuts and Bolts of a Multicenter Clinical Trial